Some of the interesting stories researchers were discussing at this year’s American Society of Microbiology meeting in San Francisco.
Covering the life sciences inside and out
Some of the interesting stories researchers were discussing at this year’s American Society of Microbiology meeting in San Francisco.
An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.
People are currently driving the planet on a crash course with global stability. Something must be done.
Financial “conflicts of interest” should not be so quickly condemned. Industry relationships are unequivocally beneficial.
African justice systems must change to help curb HIV and tuberculosis transmission in prisons.
A 30-year-old technique to record the electrical activity of neurons gets a robotic makeover.
Is the push for science to save the still flailing economy a threat to scientific research?
A growth factor isolated from human stem cells shows promising results in a mouse model of multiple sclerosis.
Successful conservation depends on an economy that doesn’t incentivize destruction of species and habitats.
Ancient bacteria living in deep-sea sediments are alive—but with metabolisms so slow that it’s hard to tell.